In the majority of CRC cases (83%) [20], the process of adenoma formation is initiated by a loss-of-function mutation genes such as tumor suppressor gene TP53, oncogenes KRAS and PIK3CA [13], or APC. The loss of APC function leads to activation of the WNT signaling pathway [21]. The gene discussed is TP53; the disease is colorectal carcinoma.